Description
Coremend is a three-component research peptide blend combining KPV, BPC-157 and Thymosin Beta-4, supplied as a lyophilized research material for in vitro and analytical laboratory applications. Provided solely for research use.
Specifications
| Compound | Coremend |
| Synonym | Three-component tissue-repair research blend |
| Sequence | 3-component blend — see blend components below |
| CAS number | See blend components |
| Molecular formula | See blend components |
| Molecular weight | See blend components |
| Purity | ≥99% · COA-verified |
| Form | Lyophilized powder |
| Content | 45 mg per vial (KPV 10 mg · BPC-157 15 mg · Thymosin Beta-4 20 mg) |
Blend components
| Component | CAS | Formula | MW |
| KPV — 10 mg | 67727-97-3 | C19H33N5O4 | 395.50 |
| BPC-157 — 15 mg | 137525-51-0 | C62H98N16O22 | 1419.55 |
| Thymosin Beta-4 — 20 mg | 77591-33-4 | C212H350N56O78S | 4963.44 |
Research applications
Analytical characterization Tissue-repair pathway research In vitro signaling Comparative peptide research
Store at −20 °C; refrigerate at 2–8 °C after laboratory handling. Consult the Safety Data Sheet for full handling guidance.
Documentation
Batch-specific identity, purity, and safety documentation.
For laboratory research use only. Not a drug, food, cosmetic, or dietary supplement. Not intended for human or veterinary use, consumption, administration, or diagnostic purposes. Sold for research purposes only.
